Skip to main content

PT-141 Efficacy Review

Meaning

This clinical and scientific evaluation assesses the therapeutic effectiveness of the synthetic peptide PT-141 (Bremelanotide) in treating hypoactive sexual desire disorder (HSDD) in women and erectile dysfunction in men, focusing on its ability to stimulate sexual arousal via central nervous system pathways. The review synthesizes clinical trial data to determine the magnitude of the desired biological response, the consistency of outcomes across diverse populations, and the profile of associated adverse effects. Efficacy is measured by validated patient-reported outcome measures.